Biodel

Global Hunter is out with its report today on Biodel (NASDAQ: BIOD), initiating BIOD at Accumulate. In a note to clients, Global Hunter writes, "We believe Biodel's key value-driver, an ultra-rapid formulation of insulin, could generate important data in 3Q11. While early, data from this study...